Appili Therapeutics Inc. APLI.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.56% | -11.86% | 4.80% | 20.49% | -668.41% |
| Total Depreciation and Amortization | 11.11% | -- | -100.00% | -7.69% | 18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.96% | 74.01% | 363.56% | -158.63% | -82.20% |
| Change in Net Operating Assets | 304.67% | -25.54% | 22.37% | -69.22% | 651.39% |
| Cash from Operations | 87.45% | -5.98% | 63.60% | -11,884.78% | -100.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -273.08% | 533.33% | 98.01% | -2.73% | 34.74% |
| Issuance of Common Stock | -- | -43.66% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 830.85% | 168.61% | 42.07% | -263.85% | 20.73% |
| Cash from Financing | 39.21% | -17.44% | 290.75% | -83.66% | 28.17% |
| Foreign Exchange rate Adjustments | -1,475.00% | 60.00% | -109.11% | 211.42% | -181.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.63% | -29.13% | 82.70% | -655.63% | -110.27% |